| # | Drug | Count |
|---|---|---|
| 0 | TERIPARATIDE | 45 |
| 1 | ETANERCEPT | 23 |
| 2 | ABALOPARATIDE | 14 |
| 3 | DULAGLUTIDE | 10 |
| 4 | ORAL SEMAGLUTIDE | 9 |
| 5 | ACETAMINOPHEN | 8 |
| 6 | BORTEZOMIB | 8 |
| 7 | DIPHENHYDRAMINE HYDROCHLORIDE | 8 |
| 8 | ERGOCALCIFEROL | 7 |
| 9 | CALCIUM | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VALERIAN | 1 | 0.0014 |
| 1 | SODIUM CHLORIDE 0.65% | 1 | 0.0007 |
| 2 | INFLIXIMAB-DYYB | 2 | 0.0006 |
| 3 | TUBERCULIN PURIFIED PROTEIN DERIVATIVE | 1 | 0.0005 |
| 4 | PLECANATIDE | 1 | 0.0005 |
| 5 | SODIUM FERRIC GLUCONATE COMPLEX | 1 | 0.0005 |
| 6 | ABALOPARATIDE | 14 | 0.0005 |
| 7 | RILUZOLE | 1 | 0.0004 |
| 8 | TERIPARATIDE | 45 | 0.0004 |
| 9 | IRON SUCROSE | 3 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Parathyroid Hormone Analog [EPC] | 45 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 26 |
| 2 | GLP-1 Receptor Agonist [EPC] | 22 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14 |
| 4 | Parathyroid Hormone-Related Peptide Analog [EPC] | 14 |
| 5 | Corticosteroid [EPC] | 13 |
| 6 | Insulin Analog [EPC] | 12 |
| 7 | Benzodiazepine [EPC] | 8 |
| 8 | PCSK9 Inhibitor [EPC] | 8 |
| 9 | Proteasome Inhibitor [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Skin Test Antigen [EPC] | 1 | 0.0005 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 3 | Parathyroid Hormone-Related Peptide Analog [EPC] | 14 | 0.0005 |
| 4 | Benzothiazole [EPC] | 1 | 0.0004 |
| 5 | Parathyroid Hormone Analog [EPC] | 45 | 0.0004 |
| 6 | PCSK9 Inhibitor [EPC] | 8 | 0.0003 |
| 7 | Parenteral Iron Replacement [EPC] | 4 | 0.0003 |
| 8 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 9 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |